Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

Thinking in New Ways

As I’ve discussed before, the market disruption wrought by MiFID was bound to see a jostling for position between the established players and the new market entrants. For the primary venues this means overcoming the inertia associated with their old operating models whilst for the new guys the imperative is to create real momentum behind their brands.

The FFI for the major European indices gives a few pointers as to the results of these efforts. Whilst fragmentation continues its inexorable rise across all the major indices – last week the FFI for the FTSE100 breached 2 for the first time – it seems likely that we will end up with a landscape that is pan-European in nature rather than country specific. The data for Chi-X and BATS seems to bear this out as their respective Top Stocks by Weekly Turnover include stocks from London, Paris, Frankfurt and Amsterdam. Turquoise appears to buck this trend as its “top ten” comprises either UK or Swiss listed stocks but, nevertheless, the idea that a primary exchange has a divine right to “own” the trading in its own country’s stocks looks increasingly likely to be a thing of the past.

To meet this challenge the primary exchanges are taking a number of different approaches. They are creating their own versions of the nimble, pan-European MTFs that have sprung up as their competitors. NYSE Euronext has now launched NYSE Arca and has signed 14 trading members to SmartPool, whilst the LSE has successfully re-aligned and launched Baikal in just a few months since the demise of its original partner, Lehmans.

The primaries have started to flex their muscles in other areas, too. Exploiting their multi- and cross-asset capabilities is an obvious way to increase the stakes. The LSE, NYSE Euronext and Deutsche Börse all have capabilities in the fixed income and derivatives arenas that the new MTFs will find difficult to emulate, for two reasons. First, there is cost: the MTF community is still focussed on proving the long-term sustainability of their existing, equity focussed business models. This means that strategic investment in adding new asset classes looks hard for them at the moment. The second is that, at least with derivatives, the exchanges actually do own the contracts being traded and so it is much harder for newcomers to wrestle liquidity in these instruments away from the incumbents.

It was interesting, therefore, to read Xavier Rolet’s comments this week that the LSE plans to launch a platform to make corporate bonds more easily accessible to the UK retail market. This will build on the MOT fixed income platform that came with its acquisition of Borsa Italiana in 2007 and is a great example of the new thinking that is emerging within the primary exchanges.

Leave a comment

Copyright © 2018 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa Group Holdings Limited.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.